by the hemostatic
system, characterized by sensitivity and variability of the
effects in response to any
impact
Klen, E.E.,
Nikitina, I.L.,
Khaliullin, F.A.,
Shepilova, S.O.,
Nikitina, E.A.,
Gaisina, G.G.,
Samorodov, A.V.,
Pavlov, V.N. (2024) , tumorigenicity, reproductive
effects, irritating
effects), low toxicity (class IV-V), and acceptable oral
URAKOV, A.L.,
MUSTAFIN, I.G.,
NABIULLINA, R.M.,
BASHIROVA, L.I.,
MOCHALOV, K.S.,
SAMORODOV, A.V.,
KHALIULLIN, F.A.,
LIPATOV, D.O.,
KORUNAS, V.I.,
KHALIMOV, A.R. (2020) There are no recommendations for assessing the
effect of potential drugs on the hemostatic system
Qian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. (2022) in DCM and to test the therapeutic
effects of MD2 inhibitor C30 on DCM. Streptozotocin (STZ) was used
Luo, W.,
Chen, X.,
Ye, L.,
Chen, X.,
Jia, W.,
Zhao, Y.,
Samorodov, A.V.,
Zhang, Y.,
Hu, X.,
Zhuang, F.,
Qian, J.,
Zheng, C.,
Liang, G.,
Wang, Y. (2021) rhizome, with anti-oxidant/anti-inflammatory
effects demonstrated in various disease models, including
Ye, L.,
Chen, X.,
Wang, M.,
Jin, L.,
Zhuang, Z.,
Yang, D.,
Guan, X.,
Samorodov, A.V.,
Pavlov, V.N.,
Chattipakorn, N.,
Feng, J.,
Wang, Y.,
Luo, W.,
Liang, G. (2021) the protective
effects of C66. Our data demonstrate a protective
effect of C66 against obesity-induced cardiac
Sultanova, .R.M,
Khusnutdinova, N.S.,
Borisova, Yu. G.,
Raskildina, G.Z.,
Meshcheryakova, S.A.,
Zlotsky, S.S.,
Valiullina, Z.A.,
Karamova, E.V.,
Samorodov, A.V. (2024) of the diterpenic acids had different
effects on the plasma component of the hemostasis system, which manifested
of neuropharmacological interaction.
Materials and methods: To study the mechanism of action of N-199/1, its
effect on 5
in medical practice to control bleeding are often inefficient and unable to lead to
effective reduction